MiRNA-based treatment for triple-negative breast cancer: miR-30c-2-3p inhibits triple-negative breast cancer via down regulation of its target gene, 19/April/2014, 6.35 am

Tumorigenesis: Oleic acid, a component of neem oil, suppresses the expression of tumor suppressor CCM1/KRTI1 via up regulation of its target gene, 19/April/2014, 6.27 am
April 19, 2014
Insight into the treatment of Metastatic Pancreatic/intestine/ovarian Cancer: Cirsiliol, a flavone isolated from Achillea fragrantissima,suppresses the expression of PDGF Receptor β via up regulation of its target gene, 19/April/2014, 8.33 am
April 19, 2014
Show all

Prof. Laurie H. Glimcher from Sandra and Edward Meyer Cancer Center of Weill Cornell Medical College, New YorkProf Matthew B. Greenblatt  from Department of Pathology, Brigham and Women’s Hospital, Harvard medical school, Boston, Massachusetts, USA; and others  had reported in the prestigious journal Nature (508, 103–107 (03 April 2014) that: XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway”

On the foundation of this interesting finding, Dr L Boominathan, Director-cum-chief Scientist of GBMD, reports here that:  MiRNA-based treatment for triple-negative breast cancer:  miR-30c-2-3p inhibits triple-negative  breast cancer via down regulation of its target gene.

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, MiRNA-based treatment for triple-negative breast cancer:  miR-30c-2-3p  inhibits triple-negative  breast cancer via down regulation of its target gene, 19/April/2014, 6.35 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Comments are closed.